PREDICT-DOLOR VE: Validation of a Structured Triage Protocol for Chronic Pain (NCT07696676) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
PREDICT-DOLOR VE: Validation of a Structured Triage Protocol for Chronic Pain
120 participantsStarted 2026-08-01
Plain-language summary
PREDICT-DOLOR VE is a structured clinical triage protocol for chronic pain that uses five internationally validated pain assessment instruments to help healthcare providers determine the appropriate level of care for patients with chronic pain. The tool operates on a free mobile-friendly platform and generates a four-level recommendation: primary care management, referral to physiatry or neurology, priority specialist evaluation, or evaluation for neurosurgical intervention.
This study will validate the diagnostic accuracy of the PREDICT-DOLOR VE algorithm by comparing its recommendations with the independent assessment of a panel of three specialists in adult patients with chronic pain (lasting 3 months or longer) across three referral centers in Venezuela. The study aims to determine whether this structured, low-cost approach can help connect patients with the right type of care more quickly and consistently.
Who can participate
Age range
18 Years – 100 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Inclusion Criteria:
* Age 18 years or older
* Chronic pain of any etiology with duration of 3 months or longer
* Ability to complete the PREDICT-DOLOR VE digital assessment battery (with assistance if needed)
* Attending one of the three participating referral centers during the recruitment period
* Provision of written informed consent before any study procedure
Exclusion Criteria:
* Acute pain with duration less than 3 months
* Active oncological pain under chemotherapy or radiotherapy protocol (separate evaluation pathway required)
* Cognitive impairment that prevents completion of self-report instruments, even with assistance
* Active psychiatric emergency or suicidal ideation at time of assessment
* Refusal to provide informed consent
* Participation in another clinical trial that could influence triage outcomes
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
At completion of each patient's assessment (single visit, approximately 15-20 minutes)
Timeframe: At completion of each patient's assessment (single visit, approximately 15-20 minutes)
2
Concordance between PREDICT-DOLOR VE algorithm and specialist panel consensus
Timeframe: At completion of each patient's assessment (single visit, approximately 15-20 minutes)